S. 36 · 118th Congress · Health
Agility in Manufacturing Preparedness Act of 2023
- IntroducedJan 24, 2023 Done
- CommitteeDied Jan 3, 2025 Stopped here
- Senate floorNot yet Not reached yet
- House floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
This bill requires the Department of Health and Human Services (HHS) to seek to contract with the National Institute for Innovation in Manufacturing Biopharmaceuticals to assess and make recommendations concerning U.S. capabilities for biopharmaceutical manufacturing and related matters. HHS must coordinate with the Biomedical Advanced Research and Development Authority on this contract.
Congressional Research Service · summary of “Introduced in Senate” version · Jan 24, 2023
Who lobbies on it
No lobbying filing on file names S. 36.
Organizations that named S. 36 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.
Actions
2 actions · newest first- Jan 24, 2023Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Jan 24, 2023Introduced in Senate